Davis's Drug Guide
ensartinibNME Drug Template
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
en-sar-ti-nib
Trade Name(s)
- Ensacove
Ther. Class.
antineoplasticsnone assigned
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "EnsartinibNME Drug Template." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580045/all/ensartinibNME_Drug_Template.
Vallerand AHA, Sanoski CAC, . EnsartinibNME Drug Template. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580045/all/ensartinibNME_Drug_Template. Accessed April 21, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). EnsartinibNME Drug Template. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580045/all/ensartinibNME_Drug_Template
Vallerand AHA, Sanoski CAC, . EnsartinibNME Drug Template [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 21]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580045/all/ensartinibNME_Drug_Template.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - ensartinibNME Drug Template
ID - 3580045
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580045/all/ensartinibNME_Drug_Template
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
